205 related articles for article (PubMed ID: 1645577)
1. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
Br J Cancer Suppl; 1991 Jun; 14():71-3. PubMed ID: 1645577
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicity.
Derbyshire EJ; Wawrzynczak EJ
Br J Cancer Suppl; 1991 Jun; 14():74-7. PubMed ID: 1645578
[TBL] [Abstract][Full Text] [Related]
3. Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen.
Wawrzynczak EJ; Derbyshire EJ; Henry RV; Parnell GD; Smith A; Waibel R; Stahel RA
Br J Cancer; 1990 Sep; 62(3):410-4. PubMed ID: 2169852
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer.
Derbyshire EJ; Stahel RA; Wawrzynczak EJ
Cancer Immunol Immunother; 1992; 35(6):417-20. PubMed ID: 1327529
[TBL] [Abstract][Full Text] [Related]
5. Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen.
Derbyshire EJ; de Leij L; Wawrzynczak EJ
Br J Cancer; 1993 Jun; 67(6):1242-7. PubMed ID: 8390281
[TBL] [Abstract][Full Text] [Related]
6. An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins.
Till M; May RD; Uhr JW; Thorpe PE; Vitetta ES
Cancer Res; 1988 Mar; 48(5):1119-23. PubMed ID: 3257712
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.
Engert A; Martin G; Pfreundschuh M; Amlot P; Hsu SM; Diehl V; Thorpe P
Cancer Res; 1990 May; 50(10):2929-35. PubMed ID: 1692251
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease.
Engert A; Burrows F; Jung W; Tazzari PL; Stein H; Pfreundschuh M; Diehl V; Thorpe P
Cancer Res; 1990 Jan; 50(1):84-8. PubMed ID: 2152774
[TBL] [Abstract][Full Text] [Related]
11. Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines.
Derbyshire EJ; Henry RV; Stahel RA; Wawrzynczak EJ
Br J Cancer; 1992 Sep; 66(3):444-51. PubMed ID: 1325825
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of an anti-human immunotoxin against bladder carcinoma and its in vitro targeting cytotoxicity].
Zhao C
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):109-11. PubMed ID: 1618077
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA
Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
16. An anti-mucin immunotoxin BrE-3-ricin A-chain is potently and selectively toxic to human small-cell lung cancer.
Derbyshire EJ; Wawrzynczak EJ
Int J Cancer; 1992 Oct; 52(4):624-30. PubMed ID: 1328073
[TBL] [Abstract][Full Text] [Related]
17. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes.
Waibel R; Mannhart M; O'Hara CJ; Brocklehurst C; Zangemeister-Wittke U; Schenker T; Lehmann HP; Weber E; Stahel RA
Cancer Res; 1993 Jun; 53(12):2840-5. PubMed ID: 7684948
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activity of a blocked ricin immunotoxin with specificity against the cluster-5A antigen associated with human small-cell lung cancer.
Zangemeister-Wittke U; Collinson AR; Fisch I; Jones RM; Waibel R; Lehman HP; Stahel RA
Int J Cancer; 1993 Jul; 54(6):1028-35. PubMed ID: 8392978
[TBL] [Abstract][Full Text] [Related]
20. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins.
Ettenson D; Sheldon K; Marks A; Houston LL; Baumal R
Anticancer Res; 1988; 8(4):833-8. PubMed ID: 3263079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]